Quest Diagnostics Q2 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 23, 2026.
Q2 2026
EPS
$3.12
est $2.82
+10.5%
Revenue
$3.04B
est $2.97B
+2.4%
Quest Diagnostics crushed Q2 earnings with a 10.5% EPS beat fueled by a 13.1% surge in testing volume, lifting the company's full-year guidance on broad momentum in Alzheimer's blood tests and cancer diagnostics.
Mentioned: DGX